ThorpHH.Behind the scenes of the CRISPR story. Science. 2021;371:1185.
2.
ElseH.How a torrent of COVID science changed research publishing—in seven charts. Nature. 2020;588:553.
3.
ClendenenNAbramsBMorabitoJGraeLMoscaMSWeitzelN.Noteworthy literature in cardiac anesthesia for 2019. Semin Cardiothorac Vasc Anesth. 2020;24:138-148.
4.
RichardsTBaikadyRRClevengerB, et alPreoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020;396:1353-1361.
5.
ZeroualNBlinCSaourM, et alRestrictive transfusion strategy after cardiac surgery. Anesthesiology. 2021;134:370-380.
6.
MazerCDWhitlockRPFergussonDA, et alSix-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med. 2018;379:1224-1233.
7.
NelsonMGreenJSpiessB, et alMeasurement of blood loss in cardiac surgery: still too much. Ann Thorac Surg. 2018;105:1176-1181.
8.
NelsonMButterworthJPalN.Restrictive versus liberal transfusion for cardiac surgery. N Engl J Med. 2018;379:2576.
9.
MassothCZarbockAMeerschM.Acute kidney injury in cardiac surgery. Crit Care Clin. 2021;37:267-278.
10.
VijayanA.Tackling AKI: prevention, timing of dialysis and follow-up. Nat Rev Nephrol. 2021;17:87-88.
11.
STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; et al.Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383:240-251.
12.
SubramaniamBShankarPShaefiS, et alEffect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: the DEXACET randomized clinical trial. JAMA. 2019;321:686-696.
13.
NappiFNennaASingSSA, et alAre the dynamic changes of the aortic root determinant for thrombosis or leaflet degeneration after transcatheter aortic valve replacement?J Thorac Dis. 2020;12:2919-2925.
14.
BaudryGSonnevilleRWaintraubX, et alExtracorporeal membrane oxygenation to support life-threatening drug-refractory electrical storm. Crit Care Med. 2020;48:e856-e863.
15.
PalNWebbLTurchioeB.Deciphering survival in electrical storm on extracorporeal membrane oxygenation: “a posteriori” (“from effect to cause”). Crit Care Med. 2021;49:e332-e333.
16.
EscobarGJLiuVXKipnisP. Automated identification of adults at risk for in-hospital clinical deterioration. Reply. N Engl J Med. 2021;384:486.
17.
PalNButterworthJ.Automated identification of adults at risk for in-hospital clinical deterioration. N Engl J Med. 2021;384:485.
18.
LandsemLeah MrossFaith JJoffeDeniseLathamGregory J. The Year in Review: Anesthesia for Congenital Heart Disease 2020. Seminars in Cardiothoracic and Vascular Anesthesia. 2021;25:107–119. doi: 10.1177/10892532211011325.
19.
SchwerzmannMRuperti-RepiladoFJBaumgartnerH, et alClinical outcome of COVID-19 in patients with adult congenital heart disease. Heart. Published online March 8, 2021. doi:10.1136/heartjnl-2020-318467
20.
CedarsAKuttySDanfordD, et alSystemic ventricular assist device support in Fontan patients: a report by ACTION. J Heart Lung Transplant. 2021;40:368-376. doi:10.1016/j.healun.2021.01.011
21.
MascioCE.Mechanical support of the failing Fontan circulation. Semin Thorac Cardiovasc Surg. 2021;33:454-458. doi:10.1053/j.semtcvs.2020.09.005
GillilandSamuelTranTimothyAlberSarahWeitzelNathaen. Year in Review 2020: Noteworthy Literature in Cardiothoracic Critical Care. Seminars in Cardiothoracic and Vascular Anesthesia. 2021;25:128–137. doi: 10.1177/10892532211016167.
24.
AlbaACForoutanFBuchanTA, et alMortality in patients with cardiogenic shock supported with VA ECMO: a systematic review and meta-analysis evaluating the impact of etiology on 29 289 patients. J Heart Lung Transplant. 2021;40:260-268.
25.
MarinacciLXMihatovND’AlessandroDA, et alExtracorporeal cardiopulmonary resuscitation (ECPR) survival: a quaternary center analysis. J Card Surg. Published online April 2, 2021. doi:10.1111/jocs.15550
26.
IllumBOdishMMinokadehA, et alEvaluation, treatment, and impact of neurologic injury in adult patients on extracorporeal membrane oxygenation: a review. Curr Treat Options Neurol. 2021;23:15.
27.
DescampsRMoussaMDBesnierE, et alAnti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study. Crit Care. 2021;25:127.
28.
MonteroSHuangFRivas-LasarteM, et alAwake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock. Eur Heart J Acute Cardiovasc Care. Published online April 5, 2021. doi:10.1093/ehjacc/zuab018
29.
JacquotALepageXMerckleLGirerdNLevyB.Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study). BMJ Open. 2019;9:e031697.
30.
CovicACopurSTapoiL, et alEfficiency of hypertonic saline in the management of decompensated heart failure: a systematic review and meta-analysis of clinical studies. Am J Cardiovasc Drugs. 2021.21:331-34. doi:10.1007/s40256-020-00453-7
31.
AcarSSanliSOztosunC, et alPharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review. Int Urol Nephrol. Published online January 3, 2021. doi:10.1007/s11255-020-02704-7
32.
GriffinMSouferAGoljoE, et alReal world use of hypertonic saline in refractory acute decompensated heart failure: a US Center’s Experience. JACC Heart Fail. 2020;8:199-208.
33.
CostanzoMR.Hypertonic saline: the genesis of the exodus of fluid in heart failure?JACC Heart Fail. 2020;8:209-211.
34.
HsiehSJOtusanyaOGershengornHB, et alStaged implementation of awakening and breathing, coordination, delirium monitoring and management, and early mobilization bundle improves patient outcomes and reduces hospital costs. Crit Care Med. 2019;47:885-893.
35.
InouyeSK.Joining forces against delirium—from organ-system care to whole-human care. N Engl J Med. 2020;382:499-501.
36.
HuckabyLVSeeseLMMathierMAHickeyGWKilicA.Intra-aortic balloon pump bridging to heart transplantation: impact of the 2018 allocation change. Circ Heart Fail. 2020;13:e006971.
37.
DhananiSHornbyLvan BeinumA, et alResumption of cardiac activity after withdrawal of life-sustaining measures. N Engl J Med. 2021;384:345-352.
38.
NalbandianASehgalKGuptaA, et alPost-acute COVID-19 syndrome. Nat Med. 2021;27:601-615.
39.
BharatAMachucaTNQuerreyM, et alEarly outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med. Published online March 31, 2021. doi:10.1016/S2213-2600(21)00077-1
40.
BharatAQuerreyMMarkovNS, et alLung transplantation for pulmonary fibrosis secondary to severe COVID-19. medRxiv. Preprint. doi:10.1101/2020.10.26.20218636
41.
ShahPRBoisenMLWingerDG, et alExtracorporeal support during bilateral sequential lung transplantation in patients with pulmonary hypertension: risk factors and outcomes. J Cardiothorac Vasc Anesth. 2017;31:418-425.
42.
AbramsBenjamin AaronWilkeyBarbara J. The Year 2020 in Review: Noteworthy Literature for Thoracic Transplant Anesthesiologists. Seminars in Cardiothoracic and Vascular Anesthesia. doi: 10.1177/10892532211007636.
43.
Brautaset EnglundKVOstbyCMRolidK, et alIntravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): a randomized clinical trial. J Heart Lung Transplant. 2021;40:359-367. doi:10.1016/j.healun.2021.01.1390
44.
MelbySJLarueSJLasalaJM, et alAnatomic distortion of the right coronary artery as a complication of lung transplantation. Ann Thorac Surg. 2010;89:2000-2001.
45.
El-EshmawiACastilloJGTangGHLAdamsDH.Developing a mitral valve center of excellence. Curr Opin Cardiol. 2018;33:155-161.
46.
PalNButterworthJ.Commentary: Mitochondria to the rescue?J Thorac Cardiovasc Surg. 2021;161:e350-e351.
47.
BansalAMehraMR.Left ventricular assist device use in biventricular configurations: it takes two to tango. J Heart Lung Transplant. 2018;37:1391-1393.
48.
CarpentierALatremouilleCCholleyB, et alFirst clinical use of a bioprosthetic total artificial heart: report of two cases. Lancet. 2015;386:1556-1563.
49.
StoneGWLindenfeldJAbrahamWT, et alTranscatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307-2318.
50.
ObadiaJFMessika-ZeitounDLeurentG, et alPercutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297-2306.
51.
GrayburnPASanninoAPackerM.Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging. 2019;12:353-362.
52.
PalNNelsonMButterworthJ.Percutaneous edge-to-edge mitral valve repair for secondary mitral regurgitation: perspectives on COAPT and MITRA-FR trials. Vessel Plus. 2019;3:39.
53.
TangGHLEstevez-LoureiroRYuYPrillingerJBZaidSPsotkaMA. Survival following edge-to-edge transcatheter mitral valve repair in patients with cardiogenic shock: a nationwide analysis. J Am Heart Assoc. 2021:e019882.
54.
WangRFFagelmanEJSmithNKSakaiT.Abdominal organ transplantation: noteworthy literature in 2020. Semin Cardiothorac Vasc Anesth. 2021;25:138–150. doi:10.1177/10892532211007256
55.
RoveJessicaClevelandJoseph CJrReeceBrett TPalJay. Noteworthy Literature of 2020: COVID Effects in Cardiac Surgery. Seminars in Cardiothoracic and Vascular Anesthesia. 2021;25:151–155. doi: 10.1177/10892532211012976
56.
MatthewsCRMillwardJBFaizaZ, et alOutcomes of surgical coronary revascularization performed before solid abdominal organ transplants. Ann Thorac Surg. 2021;111:568-575.
57.
WuEWuKDaneshjouROuyangDHoDEZouJ.How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat Med. 2021;27:582-584.
58.
AhmadFBAndersonRN.The leading causes of death in the US for 2020. JAMA. 2021;325:1829-1830. doi:10.1001/jama.2021.5469
59.
KaragiannidisCMostertCHentschkerC, et alCase characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853-862.
60.
SupadyABadulakJEvansLCurtisJRBrodieD.Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?Lancet Respir Med. 2021;9:326-328.
61.
SupadyACurtisJRAbramsD, et alAllocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks. Lancet Respir Med. 2021;9:430-434.